Juvéderm™, from the makers of Botox®, is commonly referred to as a “next generation” smooth gel. This injectable gel is indicated for injection into the mid to deep dermis for correction of moderate of severe facial wrinkles and folds. Juvéderm™ is a hyaluronic acid dermal filler approved by the FDA in June 2006, and contains the highest concentration of cross-linked hyaluronic acid of any dermal filler currently available. These elements provide optimal results with a single treatment of Juvéderm™ in the majority of patients and deliver sustained results for up to six months or longer.
The Juvéderm™ process creates a smooth gel that flows easily into the skin, creating a smooth, natural look and feel.
Juvéderm™ is generally well tolerated. The most commonly reported side effects are temporary injection site redness, swelling, pain, tenderness, firmness, lumps/bumps, and bruising. Exposure of the treated area to excessive sun and extreme cold weather should be minimized until any initial swelling and redness has resolved. Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at injection site.
As with all skin injection procedures there is a risk of infection. Juvéderm™ should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body’s immune response, as there may be an increased risk of infection. Juvéderm™ injectable gel should not be used in patients who have severe allergies marked by a history of anaphylaxis or a history or presence of multiple severe allergies.